AME Equities LLC - 15 Feb 2024 Form 3 Insider Report for Chromocell Therapeutics Corp (CHRO)

Role
10%+ Owner
Signature
AME Equities LLC, By /s/ Ruth Friedman
Issuer symbol
CHRO
Transactions as of
15 Feb 2024
Net transactions value
$0
Form type
3
Filing time
15 Feb 2024, 20:25:40 UTC

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CHRO Common Stock 351,163 15 Feb 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CHRO Senior Secured Convertible Promissory Note 15 Feb 2024 Common Stock 11,876 Direct F1, F3
holding CHRO Senior Secured Convertible Promissory Note 15 Feb 2024 Common Stock 6,138 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents $57,001.62 of outstanding principal and accrued and unpaid interest of this senior secured convertible promissory note, due February 29, 2024, which will automatically convert into 11,876 shares of common stock of the Issuer at a conversion price of 80.0% of the offering price of the securities sold to the public in the Issuer's initial public offering.
F2 Represents $29,084.97 of outstanding principal and accrued and unpaid interest of this senior secured convertible promissory note, due March 1, 2024, which will automatically convert into 6,138 shares of common stock of the Issuer at a conversion price of 80.0% of the offering price of the securities sold to the public in the Issuer's initial public offering, including an additional 78 shares of common stock issuable as consideration for this senior secured convertible promissory note.
F3 Ruth Friedman has sole voting and dispositive power over the shares held by the Reporting Person as to which Ms. Friedman disclaims beneficial ownership except to the extent of her pecuniary interest therein.

Remarks:

Exhibit 24 - Power of Attorney